Trending

protein

Takeda signs $882m rare disease alliance with Oxford biotech Evox

Takeda signs $882m rare disease alliance with Oxford biotech Evox

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week,

X

Takeda signs $882m rare disease alliance with Oxford biotech Evox

https://pharmaphorum.com/news/takeda-signs-882m-rare-disease-alliance-with-oxford-biotech-evox/

9th Annual Biologics Formulation Development and Drug Delivery Forum

9th Annual Biologics Formulation Development and Drug Delivery Forum

Formulation development for Safe Delivery to patient

X

9th Annual Biologics Formulation Development and Drug Delivery Forum

https://pharmaphorum.com/events/9th-annual-biologics-formulation-development-and-drug-delivery-forum/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com